Microscopic examination of urine for the presence of *Ceftriaxone* (a cephalosporin antibiotic) via microscopic detection of its metabolites
This test checks if your urine contains traces of a specific antibiotic used to treat bacterial infections. It helps determine whether the medication is being processed by your body.
["Assesses antibiotic presence in urine for monitoring treatment effectiveness or detecting drug-related metabolites."]
Key facts at a glance
- LOINC
- 101485-1
- Short code
- CRO MIC BC
- Synonyms
- cefTRIAXone Bld Pos MIC.VOC det
- Category
- chemistry
- Sample
- whole-blood
- Container
- Positive blood culture bottle (aerobic, anaerobic, or pediatric bottle depending on patient population) transported to the microbiology laboratory at room temperature.
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- mic-voc-detection
- CPT
- 87186
- SNOMED
- 270616009
- Specimen volume
- Blood culture bottle volume per institutional protocol; typically 8-10 mL per adult aerobic/anaerobic bottle; pediatric bottles require 1-3 mL per bottle.
- Stability
- Positive blood culture broth should be processed for AST as soon as growth is detected, ideally within 8-24 hours of positivity. Maintain at room temperature; do not refrigerate.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 24–72 hours
- Order
- routine
Why This Test Might Be Ordered
Your healthcare provider may request this test if you’re taking Ceftriaxone to treat or monitor a bacterial infection. It can also be used to check for unusual drug metabolites in your urine, especially if you’re experiencing side effects or have kidney issues.
What to Expect Before the Test
No special preparation is needed. You’ll likely provide a urine sample (midstream or catheterized) similar to a routine urine test. If you’re on a strict diet or medication, let your provider know to avoid false results.
What the Test Results Mean
Positive results indicate the presence of Ceftriaxone metabolites in your urine, confirming the drug was processed. Negative results mean no detectable metabolites were found. Results are qualitative (present/absent) rather than quantitative.
Common Reasons for Testing
This test is primarily used to confirm antibiotic exposure, evaluate drug metabolism, or investigate unusual symptoms (e.g., kidney problems) linked to Ceftriaxone use.
Reference range
Interpretive categories per CLSI M100 / EUCAST breakpoints: Susceptible (S), Susceptible-Dose Dependent (SDD/Intermediate), or Resistant (R). MIC values reported in µg/mL. Breakpoints vary by organism and infection site.N/A
No special patient preparation is required. Specimen should be collected prior to administration of the next antimicrobial dose when clinically feasible to reflect in vivo susceptibility.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance: Monitoring Drug Metabolism and Infection Response
Short name
Urine Microscopic Ceftriaxone Detection
Frequently asked questions
What does a positive result mean for my health?
Why might my provider order this test?
Can I stop taking Ceftriaxone before this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy